| Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts S Li, D Shen, J Shao, R Crowder, W Liu, A Prat, X He, S Liu, J Hoog, C Lu, ... Cell reports 4 (6), 1116-1130, 2013 | 682 | 2013 |
| Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: Results from the American College of … MJ Ellis, VJ Suman, J Hoog, R Goncalves, S Sanati, CJ Creighton, ... Journal of Clinical Oncology 35 (10), 1061-1069, 2017 | 321 | 2017 |
| Functional annotation of ESR1 gene fusions in estrogen receptor-positive breast cancer JT Lei, J Shao, J Zhang, M Iglesia, DW Chan, J Cao, M Anurag, P Singh, ... Cell reports 24 (6), 1434-1444. e7, 2018 | 97 | 2018 |
| Using multigene tests to select treatment for early-stage breast cancer R Goncalves, R Bose Journal of the National Comprehensive Cancer Network 11 (2), 174-182, 2013 | 72 | 2013 |
| New concepts in breast cancer genomics and genetics R Goncalves, WA Warner, J Luo, MJ Ellis Breast Cancer Research 16, 1-11, 2014 | 50 | 2014 |
| Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer R Goncalves, C Ma, J Luo, V Suman, MJ Ellis Nature reviews Clinical oncology 9 (4), 223-229, 2012 | 46 | 2012 |
| Implications of ESR1 mutations in hormone receptor-positive breast cancer T Reinert, R Gonçalves, J Bines Current treatment options in oncology 19, 1-13, 2018 | 39 | 2018 |
| Papillomas of the breast: factors associated with underestimation G Boufelli, MA Giannotti, CA Ruiz, N de Barros, LF Chala, JY Maesaka, ... European Journal of Cancer Prevention 27 (4), 310-314, 2018 | 35 | 2018 |
| Current status of neoadjuvant endocrine therapy in early stage breast cancer T Reinert, R Gonçalves, MJ Ellis Current Treatment Options in Oncology 19, 1-14, 2018 | 32 | 2018 |
| Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer R Goncalves, K DeSchryver, C Ma, Y Tao, J Hoog, M Cheang, E Crouch, ... Breast cancer research and treatment 165, 355-364, 2017 | 30 | 2017 |
| MRI to predict nipple involvement in breast cancer patients JRM Piato, RD Jales Alves de Andrade, LF Chala, N de Barros, MS Mano, ... American Journal of Roentgenology 206 (5), 1124-1130, 2016 | 28 | 2016 |
| Accuracy of frozen section in intraoperative margin assessment for breast-conserving surgery: A systematic review and meta-analysis JRF Mila Trementosa Garcia , Bruna Salani Mota, Natalia Cardoso, Ana Luiza ... Plos One 16 (3), 2021 | 27 | 2021 |
| Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep. 2013; 4: 1116–30 S Li, D Shen, J Shao, R Crowder, W Liu, A Prat, X He, S Liu, J Hoog, C Lu, ... Nat Genet 45, 1446-51, 2013 | 13 | 2013 |
| Eculizumab interruption in atypical hemolytic uremic syndrome due to shortage: analysis of a Brazilian cohort ME Neto, L de Moraes Soler, HVG Vasconcelos, HS Nga, AM Bravin, ... Journal of nephrology, 1-8, 2021 | 12 | 2021 |
| Multidisciplinary approach to neoadjuvant endocrine therapy in breast cancer: a comprehensive review T Reinert, S Ramalho, R Gonçalves, CH Barrios, MS Graudenz, J Bines Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and …, 2016 | 11 | 2016 |
| The oncological safety of autologous fat grafting: a systematic review and meta-analysis R Goncalves, BS Mota, B Sobreira-Lima, MD Ricci, JM Soares Jr, ... BMC cancer 22 (1), 391, 2022 | 10 | 2022 |
| Copy number alterations associated with clinical features in an underrepresented population with breast cancer RM Rodrigues‐Peres, B de S Carvalho, M Anurag, JT Lei, L Conz, ... Molecular Genetics & Genomic Medicine 7 (7), e00750, 2019 | 8 | 2019 |
| Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy JPG da Cunha, R Goncalves, F Silva, FN Aguiar, BS Mota, BB Chequim, ... Journal of Clinical Pathology 76 (4), 239-243, 2023 | 7 | 2023 |
| Ethical issues surrounding breast cancer screening in Brazil R Gonçalves, JM Soares-Jr, EC Baracat, JR Filassi Clinics 74, e1573, 2019 | 7 | 2019 |
| Avoidance of negative results in adjuvant endocrine therapy trials for estrogen receptor-positive breast cancer R Goncalves, T Reinert, MJ Ellis J Clin Oncol 35, 2718-2719, 2017 | 7 | 2017 |
Matthew J. EllisPhysician Scientist, OncologistVerified email at progendis.com
